Biosimilars Market Predicted to Cross $25 Billion by 2020 - NBC-2.com

www.nbc-2.com/.../biosimilars-market-predicted-to-cross-25-billion-by-202...

WBBH‑TV

9 hours ago - Further, the lower cost of these drugs as compared to the patented biologics, the increasing encumbrance to curb healthcare costs globally, increasing